Transforming the Specimen Imaging landscape

 

Who We Are

Founded in 2013, Perimeter Medical Imaging is a privately held medical device company with offices in Toronto, ON and Boston, MA.  Our executive team of medical device leaders holds an excellent track record of successfully building companies and improving outcomes for clinicians and patients. We are passionate about providing real time information that will allow clinicians to dramatically improve care while reducing healthcare costs.

 

 

What We Do

Perimeter develops, patents, and commercializes advanced in-procedural medical imaging tools.  The OTIS™ platform provides a crucial additional dataset to the clinician to facilitate more informed decision making that could help reduce over-sampling, lower the incidence of repeat procedures, and potentially even lower mortality rates.
 
Perimeter’s OTIS™ (Optical Tissue Imaging System) has been designed to provide clinicians with real-time, ultra-high resolution, sub-surface image volumes across the surface of an excised tissue specimen.  By providing the ability to assess microscopic tissue structures available during the clinical procedure, clinicians finally have access to information that can allow for better decisions during the procedure.  This has the potential to result in better long term outcomes for patients and lower costs to the healthcare system.

 

 
 

Leadership Team

charlescarignan.png

Charles S. Carignan, MD
Chief Executive Officer

Dr. Carignan has more than twenty (20) years of experience in medical device development and holds vast experience as a Clinician, Med-Tech Executive and Chief Executive Officer. He also has strong regulatory and reimbursement experience.  Dr. Carignan holds a Bachelor Degree from Yale University and obtained his Doctor of Medicine (M.D) from Columbia University in 1991. He trained in General Surgery at Columbia Presbyterian Medical Center.  
 
Most recently Dr. Carignan held the position of CEO at Rex Bionics Pty Limited. Prior to this, Dr. Carignan held the position of CEO at BionX Medical Technologies (now part of Ottobock) from July 2014 to March 2017. Previously Dr. Carignan was the Founder and CEO of NinePoint Medical, an OCT-based imaging technology initially used to image pathology in the esophagus, the Chief Medical Office of Novasys Medical Inc, the CMO of Boston Scientific, and the VP of Medical Affairs at Conceptus, acquired by Bayer.

 
 
paulweber.png

Paul Weber
Chief Business Officer, Founder

Mr. Weber brings extensive marketing, commercialization and international business development experience with both large multinational and growth stage medical and technology companies. Prior to joining Perimeter Medical, he led Business Development and Marketing for Covalon Technologies. In this capacity he helped to transition the company from a technology focus to a commercially focused organization, building out OEM, domestic and international distribution channels. At Sentinelle he led Business Development and Marketing, growing the company from start-up revenues to greater than $18 million in sales in 2 ½ years. After being acquired by Hologic Inc. for $105 million, Mr. Weber led Marketing, integration, and OEM and International Distribution relationships. Mr. Weber has also had leadership roles in business development and product management capacities with Johnson and Johnson, Christie Digital and has consulted for numerous technology start-ups on growth strategies. He has developed and taught MBA courses in Marketing and Commercialization of Technology and holds a BA in Psychology and an MBA from Wilfrid Laurier University.

 
 
briangoffenberg.png

Brian Goffenberg
Chief Financial Officer

Mr. Goffenberg has expertise in financial management of information technology firms, including Medworkxx Solutions Inc., Philips Lifeline, DWL Incorporated and Delrina Corporation, both before and after its 1995 sale to Symantec Corporation. He has served as a financial partner and business advocate within a varied scope of organizations - and has served in leadership roles throughout trajectories of up to triple revenue growth. In addition to certification from the Canadian Institute of Chartered Accountants, Brian holds Bachelor degrees in Commerce and Accounting from University of the Witwatersrand, Johannesburg, South Africa.

 
 
andrewberkeley.png

Andrew Berkeley
Business Development, Founder

Mr. Berkeley brings over 15 years of experience in the optical and medical imaging space. He has held technical and leadership roles at multiple start-up companies with responsibilities in market development, new product introduction, product development and service, and business development. Andrew holds a degree in Electronic Engineering from the Institute of Technology Tallaght and a Masters in Optical Electronic Engineering from the University of Hull.

 
 
elizabethmunroe.png

Elizabeth Munro
Quality and Regulatory Affairs, Founder

Ms. Munro is an experienced project manager and biomedical engineer with over ten years of experience in the startup and technology innovation space. She brings hands-on experience with development of multiple novel optical imaging modalities and has a track record of effectively driving aggressive product development timelines. Elizabeth holds a B.Sc. (Hons) in Physics from McGill University and an M.A.Sc. in Biomedical Engineering from the University of Toronto.

 
 
carlg.png

Carl Gazdzinski
Engineering

Mr. Gazdzinski brings over 14 years of progressive experience in medical device engineering and development. He has worked in technical and leadership roles in which ground-up technology innovation was hardened into product suitable for manufacturing and subsequently launched commercially with success. Carl has a proven track record of contributing to and leading dynamic teams that execute on deliverables and build value. He provides experience spanning both start-up and established OEM environments, including team leadership through merger and acquisition. Carl holds a B.Sc. in Biology, B.Eng. in Mechanical Engineering and an M.Sc. in Medical Biophysics (all from the University of Western Ontario).

 
 
christinedanner.png

Christine Danner
Clinical Applications and Training

Ms. Danner brings over ten years of experience in the medical device industry including start-ups in diagnostic imaging, and most recently managed the clinical applications MRI program at Hologic (former Sentinelle Medical division). She has been focused on developing clinical training programs and involved with product development, including personally impacting product and process design enhancements. She has been a key driver behind the ramp up and management of a Canadian and US based customer facing clinical applications team, has managed relationships with OEMs specifically in cross training collaborations, and has provided leadership through company acquisitions. Christine holds a B.A. (Hons) from the University of Western Ontario and a M.A. from York University.

 
 
rocky.png

Rochelle ‘Rocky’ Keen
Clinical Research Programs

Ms. Keen is a product development and clinical trials leader with a proven track record in the healthcare capital equipment industry, with over 25 years of experience specializing in women’s health imaging. She has a strong background in big company culture as well as proven success in small growth companies. She specializes in developing advanced imaging technology in growing markets. She has managed product development and clinical trials in the U.S. and international markets. Most recently she managed product development and clinical trials for Gamma Medica, Inc. Rochelle holds a degree in Radiologic Technology from the University of Maryland Medical Center, Baltimore, MD.

 
 
David.png

David Rempel, Research and Development

Mr. Rempel has seven years of experience in diagnostic imaging including technical and research roles in three startups. His expertise is centered on medical imaging techniques with an emphasis on image analysis, novel imaging device development, and radiation dose delivery assessment. David holds a B.Sc. in Physics and an M.Sc. in Medical Physics (both from McGill University).

 

 
 

 
 

Board of Directors

Doug Janzen
Chairman

Mr. Janzen has been involved in the Life Sciences industry for the past 19 years. He currently is the Founder and President of NorthView Ventures, an entity which invests in and provides strategic advisory services to a number of technology companies. Prior to that, he was President and CEO of Cardiome Pharma, a NASDAQ listed drug development company that raised over $300M from investors and completed over $1Billion in licensing deals during his tenure. In 2010 Cardiome’s lead product Brinavess was approved and launched in Europe by Merck. Prior to that, Mr. Janzen was an investment banker with Cormark Securities, acting as Managing Director of Life Sciences. Mr. Janzen is a past winner of Vancouver’s Top 40 under 40 award, is the past Chairman of Life Sciences British Columbia, has served as a Director of Biotech Canada and sits as a Director on a number of public and private boards.

 

 

Charles S. Carignan, MD
Chief Executive Officer, Director

Dr. Carignan has more than twenty (20) years of experience in medical device development and holds vast experience as a Clinician, Med-Tech Executive and Chief Executive Officer. He also has strong regulatory and reimbursement experience.  Dr. Carignan holds a Bachelor Degree from Yale University and obtained his Doctor of Medicine (M.D) from Columbia University in 1991. He trained in General Surgery at Columbia Presbyterian Medical Center.  
 
Most recently Dr. Carignan held the position of CEO at Rex Bionics Pty Limited. Prior to this, Dr. Carignan held the position of CEO at BionX Medical Technologies (now part of Ottobock) from July 2014 to March 2017. Previously Dr. Carignan was the Founder and CEO of NinePoint Medical, an OCT-based imaging technology initially used to image pathology in the esophagus, the Chief Medical Office of Novasys Medical Inc, the CMO of Boston Scientific, and the VP of Medical Affairs at Conceptus, acquired by Bayer.

 
 
 

Suzanne Foster, M.Ed, MPH
Director

Mrs. Foster is a proven business leader, a breast cancer survivor, and a passionate patient advocate. As general manager of Medtronic Transformative Solutions, Mrs. Foster led the development and acquisition of several technologies that are improving the way critical procedures are performed and thereby advancing patient care. During her tenure at Medtronic, the business achieved double-digit revenue growth for the past seven years and experienced significant global market adoption.

Mrs. Foster is a frequent speaker on topics related to finding ways to advance technology and procedural innovation in breast cancer care. In March 2018, The National Consortium of Breast Centers (NCBC) awarded her with their Inspiration Award, which recognizes someone who has gone above and beyond towards improving breast cancer care.  Mrs. Foster has also been recognized for her work in employee engagement and diversity. Notable achievements include:

— #1 Best Place to Work in New Hampshire, Business NH Magazine, 2014-2017
— Business Excellence Award in Manufacturing, New Hampshire Business Review, 2017

Mrs. Foster has a BA in Communication from University of New Hampshire, M.Ed in Psychology from Notre Dame College, JD Law from Suffolk Law School and a Masters in Public Health (Law and Health Policy) from Harvard School of Public Health.

 

Frank Prendergast, MD
Director

Dr. Prendergast has held senior positions within Mayo Clinic: Chair, Department of Biochemistry & Molecular Biology; Director for Research, Mayo Clinic Rochester,‘89-‘92. Member of the Board of Governors for Mayo Clinic in Rochester; Mayo Clinic Board of Trustees,‘92-‘09; Mayo Clinic’s Board of Governors, ‘99-‘06. Mayo Distinguished Investigator, Emeritus Director of the Mayo Clinic Comprehensive Cancer Center and Emeritus Director of Mayo Center for Individualized Medicine.
 
Frank also served extensively for the National Institutes of Health, Board of Advisors for Division of Research Grants; National Advisory General Medical Sciences Council; Board of Scientific Advisors of National Cancer Institute; National Cancer Advisory Board.
 
He has received the following honors and awards: Rhodes Scholarship; DSc Purdue University and University West Indies, Outstanding Graduate from University West Indies; Outstanding Graduate College of Biological Sciences from University of Minnesota; Musgrave Gold Medal Institute of Jamaica.
 
Frank holds a medical degree with honors from University of West Indies; Oxford University Rhodes Scholar M.A. degree in physiology. After internal medicine residency at Mayo Clinic, he obtained the Ph.D. degree in biochemistry at University of Minnesota/Mayo Graduate School.

 
 
 

Paul Magnin, PHD
Director

Dr. Magnin spent 17 years as a key contributor to Hewlet-Packard's Ultrasound Imaging business. He was the General Manager of Hewlett-Packard's Imaging Systems business from January 1996 through 1998. From 1998 through 2003, Dr. Magnin was the President and CEO of LightLab Imaging, a medical device start-up company. LightLab developed a proprietary Optical Coherence Tomography technology that employs infrared light to make images with resolution on the micron scale for Cardiology, Endoscopy, Neurology, and Surgical Microscopy. Subsequently he was the Founder and President of Novelis, Inc. a privately funded start-up focused on guiding therapy for Interventional Cardiology applications. Novelis was sold to Volcano Corporation in 2008. Dr. Magnin is an advisor and board member of a number of medical device start-up companies. He holds over 16 patents and has authored over 20 scientific journal articles. He has been studying and working in medical imaging since 1977 while an undergraduate at Princeton University. In 1981 he completed his doctorate in Biomedical Engineering at Duke University where he was part of the Ultrasonic Imaging research team.

 

Hugh Cleland
Director

Mr. Cleland is co-founder and principal at Roadmap Capital, and Portfolio Manager of the Roadmap Innovation Funds. Mr. Cleland has a Bachelor of Arts (Honours, 1992/97) from Harvard University and earned his CFA designation in 2001. He was founding portfolio manager at Northern Rivers Capital Management (“Northern Rivers”), where he managed the Northern Rivers Innovation Fund from May of 2001 until Northern Rivers was acquired by BluMont Capital in February of 2010. He co-founded Roadmap Capital Inc. in the summer of 2013. Roadmap and its investors have now invested more than $120M in VC-stage tech companies. Sectors include semiconductors, material sciences, and medical devices. Mr. Cleland is now a member of the Board of Directors of Ubilite Inc and Perimeter Medical Imaging, and is an observer on the Board of Peraso Technologies and MMB Networks.  Prior to Northern Rivers, Mr. Cleland also held various roles at Midland Walwyn Capital and Interward Capital Corporation.

 

 
 
 

Stephen Ireland
Director

Mr. Ireland is the Healthcare Principal at Roadmap Capital and brings more than 25 years of experience in healthcare. As the former Senior Vice-President, Business Development at TransTech Pharma, Mr. Ireland managed transactions in 2006 and 2010 with Pfizer and Forest Laboratories, respectively, valued in excess of $2 billion in potential upfront fees and milestones, each with recurring double-digit royalties. Mr. Ireland brings international experience in business development, clinical development, research, sales, marketing and executive management to Perimeter's board.

 
 

 
 

Advisary Board

Ted James, MD, MS, FACS
Vice Chair Academic Affairs
Chief of Breast Surgical Oncology
Beth Israel Deaconess Medical Center
Harvard Medical School

A member of the BIDMC/Harvard health system, Dr. Ted James manages the surgical care of breast cancer patients. He performs advanced breast surgical oncology procedures including oncoplastic and minimally invasive breast surgery. Dr. James also takes an active role promoting quality initiatives in cancer care delivery. He is active in research on improving outcomes in breast cancer surgery, including margin control during breast conserving surgery.

Dr. James employs a multidisciplinary, team-based approach to cancer care and believes that patients should be key members of the treatment decision-making process. He educates patients about their diagnosis and addresses their treatment priorities. He believes that care must also be compassionate and focus on the entire person including their physical, emotional and spiritual well-being.

In addition to his medical and surgical training, Dr. James obtained a Health Care Management degree from Harvard. Dr. James is also faculty at Harvard Medical School and serves in leadership roles with the Commission on Cancer and American Cancer Society. He is a fellow of the American College of Surgeons and member of the Society of Surgical Oncology and American Society of Breast Surgeons.

 

Frank Prendergast, MD
Former Director
Mayo Clinic Comprehensive Cancer Center

Dr. Prendergast has held senior positions within Mayo Clinic: Chair, Department of Biochemistry & Molecular Biology; Director for Research, Mayo Clinic Rochester,‘89-‘92. Member of the Board of Governors for Mayo Clinic in Rochester; Mayo Clinic Board of Trustees,‘92-‘09; Mayo Clinic’s Board of Governors, ‘99-‘06. Mayo Distinguished Investigator, Emeritus Director of the Mayo Clinic Comprehensive Cancer Center and Emeritus Director of Mayo Center for Individualized Medicine.
 
Frank also served extensively for the National Institutes of Health, Board of Advisors for Division of Research Grants; National Advisory General Medical Sciences Council; Board of Scientific Advisors of National Cancer Institute; National Cancer Advisory Board.
 
He has received the following honors and awards: Rhodes Scholarship; DSc Purdue University and University West Indies, Outstanding Graduate from University West Indies; Outstanding Graduate College of Biological Sciences from University of Minnesota; Musgrave Gold Medal Institute of Jamaica.
 
Frank holds a medical degree with honors from University of West Indies; Oxford University Rhodes Scholar M.A. degree in physiology. After internal medicine residency at Mayo Clinic, he obtained the Ph.D. degree in biochemistry at University of Minnesota/Mayo Graduate School.

 
 
 

Juliann Reiland, MD, FACS
Chair, ASBrS Oncoloplastic Surgery Work Group
Avera, University of South Dakota Sanford School of Medicine, Vermillion, Medical School

Dr. Reiland is a board certified surgeon specializing in breast cancer surgery with an emphasis in oncoplastic surgery and IOERT procedures.  Dr. Reiland is currently the Medical Director of Avera McKennan’s IOERT Breast Program. She has had 23 years of surgical experience, with more than 11 years dedicated exclusively to breast surgery. Dr. Juliann’s passion for Breast Conserving Surgery is well known. She is a prominent speaker both Nationally and Internationally regarding surgical approaches to breast cancer for the best clinical and cosmetic results. She has incorporated the most advanced approaches for breast cancer treatment, including sentinel node biopsy, accelerated partial breast radiation and oncoplastic surgical techniques.

 

 

Brian Wilson, PHD
Head, Div of Biophysics & imaging, Ontario Cancer Institute, Princess Margaret Cancer Center

Dr. Wilson leads an internationally recognized R&D program in optics-based biomedical applications, with a primary translational / clinical focus. Dr. Wilson has published over 300 peer-reviewed papers in basic, translational and clinical research, and has trained more than 60 graduate students and postdoctoral and clinical fellows. He holds or has held several international Visiting Appointments (Harvard, USA; Saõ Paulo, Brazil; Fujian, China; Western Australia) and is involved in many national and international collaborations.

 
 
 

Gordon Cheung, MD
Radiologist, Medical Director of MRI/CT at CML Healthcare

Dr. Cheung is Medical Director of MRI/CT at CML HealthCare, one of the largest medical imaging practices in Canada. He is Consultant in Medical Imaging, Division of Neuroradiology and Interventional Neuroradiology at Sunnybrook Health Sciences Center; and Assistant Professor at the University of Toronto. From 1990 to 2003, Dr. Cheung was the Clinical Director of MRI at Sunnybrook Health Sciences Center. Dr. Cheung is also an entrepreneur, a founding partner of TUC Managed IT Solutions, and a founder of Excelion Technology.